Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Chemmedchem|November 16, 2020
The Young Scientists Network: How the European Federation for Medicinal Chemistry (EFMC) Became Young AgainKristina Goncharenko, Michele Mari, Yves P Auberson, et al.
Annals of Neurology|October 8, 2004
Prolongation of levodopa responses by glycineB antagonists in parkinsonian primatesStella M Papa, Yves P Auberson, J Timothy Greenamyre
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 30, 2014
The role of GluN2A and GluN2B subunits on the effects of NMDA receptor antagonists in modeling schizophrenia and treating refractory depressionLaura Jiménez-Sánchez, Leticia Campa, Yves P Auberson, et al.
Chemmedchem|May 20, 2016
Ligand Specific Efficiency (LSE) Index for PET Tracer OptimizationYves P Auberson, Emmanuelle Briard, David Sykes, et al.
Chemmedchem|December 20, 2022
The Facets of Diversity: The EFMC PerspectiveChiara Borsari, Brieuc Matagne, Kristina Goncharenko, et al.
Translational Psychiatry|April 19, 2018
Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonistMarta Gordillo-Salas, Fuencisla Pilar-Cuéllar, Yves P Auberson, et al.
Chemmedchem|July 19, 2025
Estimation of In Vivo Half-Life From In Vitro Metabolic Clearance, Protein, and Cell Membrane Affinity AssaysCarla Pou Miralbell, Sandrine Desrayaud, Berndt Oberhauser, et al.
Chemmedchem|April 18, 2024
Developing Low Molecular Weight PET and SPECT Imaging AgentsLian Xue, Caitlin V M L Jie, Sandrine Desrayaud, et al.
Pageof 6